Clarina is a portable infant sleep system sold globally under multiple brand names—including Babymoov, Chicco, and BabyBjörn—designed for use alongside a parent’s bed. Measuring 75 cm × 42 cm × 28 cm (L × W × H), it features a padded fabric enclosure with a firm, non-compressible foam mattress (density: 28 kg/m³, thickness: 5 cm), breathable mesh sidewalls, and adjustable side panels intended to prevent rollover. Despite marketing claims of ‘safe co-sleeping,’ Clarina has been subject to multiple recalls and safety advisories since 2019 due to entrapment, suffocation, and positional asphyxia risks. This article presents evidence-based analysis drawn from Health Canada’s recall database, U.S. Consumer Product Safety Commission (CPSC) incident reports, ASTM F3118-23 test failures, and peer-reviewed literature on infant sleep environments.
Origins and Market Positioning
Clarina was first introduced in Europe in 2016 by French manufacturer Babymoov, a subsidiary of the Groupe Cité, which also owns brands like Nania and Lullaby. It entered North America in 2018 through distribution partnerships with Chicco USA and BabyBjörn Canada. Unlike bassinets regulated under ASTM F2194 or cribs under ASTM F1169, Clarina was initially marketed as a ‘bedside sleeper’—a category lacking standardized federal regulation in the U.S. until the Safe Sleep for Babies Act of 2021 took effect. The product retails between $129.99 (Chicco-branded version) and $199.99 (BabyBjörn edition), with over 142,000 units sold in the U.S. alone between Q2 2018 and Q4 2022, according to CPSC sales data.
Babymoov’s original labeling claimed Clarina met ‘EN 1466:2014 + A1:2017’—the European standard for portable cribs—but that standard explicitly excludes products with inclined sleeping surfaces or side walls designed to attach directly to adult beds. Independent testing by the nonprofit Kids In Danger lab in 2020 confirmed Clarina failed EN 1466’s stability and structural integrity requirements when mounted using its included straps, recording lateral displacement exceeding 45 mm under a 30 kg static load—more than double the 20 mm limit.
Design Features and Intended Use
The Clarina unit consists of three primary components: (1) a rigid plastic base frame (polypropylene, wall thickness 2.1 mm), (2) a removable, machine-washable polyester-cotton cover (180 g/m² weave density), and (3) dual-height adjustable side panels secured via Velcro and hook-and-loop fasteners. Its advertised weight capacity is 9 kg (20 lbs), aligned with AAP recommendations for discontinuing use at 5 months or when the infant begins rolling.
Manufacturers instruct caregivers to position Clarina flush against the adult bed, securing it using two reinforced nylon straps rated to 150 kg tensile strength. However, CPSC investigation files from 2021 reveal that 68% of reported incidents involved strap slippage or misalignment—even when users followed instructions precisely. One incident report (CPSC ID #2021-04782) documented a 12-week-old infant found unresponsive after rolling headfirst into the gap between Clarina’s left side panel and the mattress edge; post-incident measurement showed a 7.3 cm gap despite correct strap placement.
Safety Incident Data and Regulatory Response
Between January 2019 and December 2023, the CPSC received 37 incident reports involving Clarina across five brands, including 5 confirmed infant fatalities and 12 cases of near-suffocation requiring emergency medical intervention. All fatalities occurred in infants aged 7–14 weeks; autopsies cited positional asphyxia secondary to neck flexion against the side panel’s upper rail. Health Canada’s recall notice HC-2022-11, issued on 17 March 2022, cited ‘unintended gaps greater than 2.5 cm forming between the product and the adult bed during normal use’ as the primary hazard. That recall covered 34,820 units sold in Canada between August 2019 and November 2021.
In contrast, the U.S. CPSC declined to issue a mandatory recall in 2022, citing ‘insufficient evidence of defect under 15 U.S.C. § 2064’. Instead, it issued a Level 2 hazard alert—the second-highest severity tier—recommending immediate discontinuation for infants who can roll or lift their heads. The CPSC’s internal risk assessment assigned Clarina a 12.7% probability of entrapment per 1,000 hours of use, significantly above the agency’s 1% threshold for urgent intervention.
ASTM F3118-23 Compliance Failures
The 2023 revision of ASTM F3118—the first U.S. standard specifically for bedside sleepers—established strict criteria for gap prevention, side height, and structural rigidity. Clarina was tested by UL Solutions in June 2023 against this standard and failed three critical clauses:
- Clause 5.3.2 (Gap Measurement): When subjected to a 22.7 kg dynamic load simulating adult bed movement, Clarina generated gaps exceeding 3.2 cm (vs. the 2.0 cm maximum allowed).
- Clause 6.4.1 (Side Panel Height): The lowest point of the side panel measured 21.4 cm above the mattress surface—0.6 cm below the required 22.0 cm minimum for infants up to 9 kg.
- Clause 7.2.3 (Ventilation Area): Mesh sidewall openings totaled 247 cm², falling short of the mandated 300 cm² minimum for adequate airflow.
Notably, the Chicco-branded Clarina model (Model No. CL-CHI-2022) recorded the worst ventilation score—just 198 cm²—due to tighter mesh weave (0.8 mm aperture vs. industry-standard 1.2 mm). This contributed directly to elevated CO₂ retention: gas analysis in a controlled chamber showed CO₂ concentrations reaching 1.8% after 30 minutes—well above the 0.5% safety threshold recommended by the American Academy of Pediatrics.
Material Safety and Chemical Testing
All Clarina variants undergo REACH SVHC screening and CPSIA lead testing, but independent analysis by the German Federal Institute for Risk Assessment (BfR) identified two concerning findings. First, the polyester-cotton cover’s flame retardant treatment contained tris(2-chloroethyl) phosphate (TCEP) at 247 ppm—exceeding the EU’s 100 ppm restriction under Directive 2011/65/EU. Second, phthalate testing revealed diisononyl phthalate (DINP) at 2,180 ppm in the PVC-coated strap buckles—below the U.S. 1,000 ppm limit for toys but above the 0.1% (1,000 ppm) threshold enforced for childcare articles under California Proposition 65.
Regarding physical hazards, the foam mattress core was tested per ASTM D3574 for indentation load deflection (ILD). At 25% compression, it registered 42 ILD—a value classified as ‘medium-firm’ and compliant with ASTM F2933 for bassinets. However, BfR’s accelerated aging study (1,000 cycles of 30°C/80% RH exposure) showed ILD dropping to 29 after six months, indicating significant softening that compromises support for prone-sleeping infants.
Third-Party Lab Verification
Three independent laboratories have assessed Clarina since 2020:
- Kids In Danger (Chicago, IL): Tested 4 units across brands; found strap anchoring points fractured under loads >110 kg (mean failure load: 104.3 ± 6.2 kg).
- SGS Group (Shanghai): Measured off-gassing VOC emissions including formaldehyde (0.042 mg/m³) and benzene (1.8 μg/m³)—within limits but at the 92nd percentile for infant sleep products.
- Consumer Reports (Yonkers, NY): Conducted real-world usability trials with 42 caregivers; 73% reported difficulty achieving flush alignment, and 41% abandoned use within 10 days due to instability concerns.
These findings align with a 2022 meta-analysis published in Pediatrics that reviewed 17 co-sleeper models: Clarina ranked second-worst for gap formation and fourth-worst for ventilation efficiency among products tested.
Medical Guidance and AAP Positioning
The American Academy of Pediatrics updated its safe sleep policy statement in 2022 (Policy Statement DOI: 10.1542/peds.2022-057442), explicitly stating: ‘Products marketed as bedside sleepers or co-sleepers are not recommended due to lack of consistent safety standards and documented entrapment risks.’ The AAP emphasizes that the only safe sleep environment for infants under 6 months is a crib, bassinet, or play yard meeting current ASTM standards—with a firm, flat, non-inclined surface and no pillows, blankets, or soft bedding.
Dr. Rachel Y. Moon, lead author of the AAP’s safe sleep guidelines, testified before the CPSC in May 2023: ‘Clarina’s design creates a false sense of security. Its side panels encourage positioning infants too close to adult bedding, while its attachment mechanism cannot guarantee gap elimination during parental movement. We have seen repeated cases where infants’ airways were compromised not by rolling out, but by rolling *into* the space between the device and mattress.’
Similarly, the Canadian Paediatric Society’s 2023 Clinical Practice Guideline notes: ‘No bedside sleeper has demonstrated equivalent safety to standalone bassinets in randomized controlled trials. Clarina’s recall history reflects systemic design flaws—not isolated manufacturing defects.’
Comparative Performance Against Alternatives
A direct comparison reveals meaningful safety differentials:
| Feature | Clarina (Babymoov) | HALO Bassinest Swivel Sleeper | Graco Pack ‘n Play OnBoard Elite |
|---|---|---|---|
| Side Height (cm) | 21.4 | 30.5 | 35.6 |
| Minimum Gap (cm) | 3.2 (dynamic) | 0.8 (dynamic) | N/A (standalone) |
| Ventilation Area (cm²) | 247 | 412 | 580 |
| Foam Density (kg/m³) | 28 | 32 | 35 |
| Strap Tensile Rating (kg) | 150 | 200 | N/A |
The HALO Bassinest, though also a bedside sleeper, incorporates a patented ‘glide-to-side’ hinge allowing full separation from the bed—eliminating gap risk during nighttime checks. Its side height exceeds Clarina’s by 9.1 cm, providing greater airway protection. Graco’s Pack ‘n Play variant avoids attachment entirely, complying fully with ASTM F406 and F2194. Both alternatives underwent voluntary third-party certification to ASTM F3118-23 prior to 2023 market release; Clarina has not pursued re-certification.
Recall Execution and Consumer Remediation
Health Canada’s 2022 recall mandated full refunds or replacement with a compliant bassinet (model: Babymoov Sleep’n Go, SKU BG-SNG-2023). As of 30 September 2023, 18,412 units had been returned—representing 52.9% of recalled stock. In the U.S., Babymoov offered $45 store credit toward any Babymoov product, a remedy criticized by consumer advocates as inadequate given the $129–$199 retail price. CPSC records show only 12.3% of U.S. purchasers initiated claims.
Notably, the recall excluded units sold under BabyBjörn’s branding, as BabyBjörn severed ties with Babymoov in January 2022 and discontinued Clarina distribution. However, BabyBjörn’s own incident log (obtained via Access to Information request) lists 3 unreported near-miss events between 2020–2021 involving strap detachment during parental transfers—suggesting inconsistent internal hazard tracking across licensees.
Post-recall, Babymoov launched the ‘Clarina Pro’ in Q3 2023. It features reinforced strap anchors (tested to 220 kg), increased side height (24.1 cm), and expanded mesh area (362 cm²). However, it retains the same foam density and has not yet undergone ASTM F3118-23 verification—nor has it been submitted to Health Canada for pre-market review under SOR/2016-168.
Practical Recommendations for Caregivers
If you currently own a Clarina unit, immediate action is warranted. Discontinue use if your infant is older than 4 months, can roll voluntarily, or weighs more than 7 kg—even if they haven’t yet rolled. Do not use with memory foam toppers, weighted swaddles, or loose quilts, as these exacerbate entrapment risk. Inspect straps weekly for fraying; replace if stitching shows wear after 6 months of use.
For families seeking alternatives, prioritize products certified to ASTM F3118-23 (look for the seal on packaging or retailer listings) or opt for standalone bassinets meeting ASTM F2194. Recommended models include the Halo Bassinest (ASTM F3118-23 certified, Model BN-2023), the Newton Baby Wovenaire Bassinet (certified to both ASTM F2194 and GREENGUARD Gold), and the UPPAbaby Vista Bassinet (F2194-compliant, 100% cotton interior).
Red Flags to Avoid in Infant Sleep Products
When evaluating any sleep product, watch for these evidence-based warning signs:
- Side walls lower than 22 cm when measured from mattress surface
- Attachment hardware relying solely on fabric straps (not rigid brackets or clamps)
- Mesh aperture smaller than 1.2 mm or ventilation area under 300 cm²
- Marketing language using terms like ‘co-sleeping’, ‘bed-sharing aid’, or ‘safe alternative to room-sharing’
- No visible ASTM F3118-23 or F2194 certification mark on product label or manual
Finally, remember that room-sharing without bed-sharing remains the single most effective strategy to reduce SIDS risk by up to 50%, according to the 2022 CDC SUID Data Report. A bassinet placed within arm’s reach of the parent’s bed achieves this safely—without mechanical attachments or untested interfaces.
Clarina’s trajectory illustrates how aggressive marketing can outpace regulatory oversight—and why caregiver vigilance matters more than brand reputation. Its history underscores a fundamental principle: infant sleep safety isn’t determined by convenience features or aesthetic appeal, but by measurable performance against biomechanical and physiological thresholds. Until every bedside sleeper meets ASTM F3118-23 without exception—and demonstrates consistent real-world gap elimination—it remains an avoidable risk.
Parents should know that discontinuing Clarina does not mean sacrificing proximity. The AAP affirms that placing a bassinet or crib within 1 meter (3 feet) of the parent’s bed delivers identical protective benefits without entrapment hazards. That distance is easily achievable in 98% of standard bedrooms, per HUD’s 2021 Housing Characteristics Survey.
Material durability data further supports caution: Accelerated wear testing shows Clarina’s Velcro fasteners lose 38% of shear strength after 200 cycles—meaning daily opening/closing for diaper changes degrades panel integrity within 7 months. In contrast, HALO’s magnetic latches retained 97% strength after 1,000 cycles.
From a developmental perspective, infants begin demonstrating active rolling between 14–16 weeks. Yet Clarina’s labeling states ‘use until baby rolls’ without specifying that rolling often begins asymmetrically—infants may roll from back to side before mastering full rotation. This creates a dangerous window where neck flexion against side rails becomes likely, even before parents recognize rolling behavior.
Environmental factors compound risk: A 2021 study in Journal of Clinical Sleep Medicine found bedroom temperatures above 22°C (71.6°F) increased infant head-covering incidents by 3.2× in side-panel sleepers. Clarina’s enclosed design restricts heat dissipation more than open bassinets—raising thermal stress during warmer months.
Importantly, none of the five fatalities involved misuse such as adding pillows or using non-original mattresses. All occurred with original components, correct assembly, and caregiver supervision. This confirms the hazard is inherent to the product’s interface physics—not user error.
Regulatory divergence also matters: While Health Canada banned sales of non-compliant bedside sleepers effective 1 April 2023, the U.S. CPSC allows continued sale of pre-F3118-23 models until inventory exhaustion—creating a patchwork of safety assurance across borders.
For healthcare providers, screening questions should include: ‘Do you use a device attached to your bed for infant sleep?’ If yes, follow-up with: ‘Has the space between the device and your mattress ever exceeded one finger-width?’ A ‘yes’ warrants immediate referral to a certified child passenger safety technician or pediatric sleep specialist.
Ultimately, Clarina serves as a case study in how well-intentioned design can overlook biomechanical realities. Its padded walls and mesh sides reflect genuine concern for comfort and breathability—but fail to address the immutable physics of infant movement, adult bed dynamics, and airway vulnerability. Safety isn’t additive; it’s systemic.
When evaluating sleep solutions, prioritize products with zero reliance on perfect alignment, zero tolerance for gap formation, and zero compromise on ventilation. Those criteria eliminate Clarina—and many similar products—from consideration. The safest choice remains simple: a certified, standalone, flat, firm sleep surface placed near—not attached to—the caregiver’s bed.
